Nabh Pharmaceuticals Private Limited
About Nabh Pharmaceuticals Private Limited
Data last updated:
Nabh Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 02 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2016PTC289196. Its GSTIN is 10AAFCN1121K1Z2 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhavesh Kumar Singh and Niraj Kumar Mishra.
Its last annual general meeting (AGM) was held on 31 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.301 Khasra No – 69/10 Ground Floor Anand Pur Dham Village Kar, Ala City, New Delhi, Delhi, India – 110081.
As per the financials filed for FY 2026, the company reported a revenue of ₹16,398, a decline of 83% compared to the previous year. For the same year it recorded a net loss of ₹1.32 Lakh and EBITDA of -₹1.25 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 55% over three years and 48% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nabh Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No.301 Khasra No – 69/10 Ground Floor Anand Pur Dham Village Kar, Ala City, New Delhi, Delhi, India – 110081
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Nabh Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nabh Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nabh Pharmaceuticals Private Limited, buy the company report.
Financials of Nabh Pharmaceuticals Private Limited
FY 2025 filings availableNabh Pharmaceuticals Private Limited reported revenue of ₹16,398 (down 83% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 83% fall in the latest year. EBITDA fell 399% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nabh Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nabh Pharmaceuticals Private Limited
Nabh Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavesh Kumar Singh | Director | 02 Jan 2016 | 10 Years 9 Months | Current |
| Niraj Kumar Mishra | Director | 02 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Nabh Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Granite Pharmaceuticals Private Limited | ₹96,921 (FY 2025) | -71.0% | Patna, Bihar, India | |||
| Medglobe Pharmaceuticals Private Limited | ₹96,163 (FY 2024) | Noida, Uttar Pradesh, India | ||||
| Optimize Pharmaceuticals Private Limited | ₹95,170 (FY 2021) | Samastipur, Bihar, India | ||||
| Nabh Pharmaceuticals Private Limitedthis company | ₹16,398 (FY 2026) | -₹1.32 Lakh | -83.0% | New Delhi, Delhi, India |
To see the full peer comparison of Nabh Pharmaceuticals Private Limited, buy the company report.
Auditor
Nabh Pharmaceuticals Private Limited is audited by CA HEMANT GUPTA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CA HEMANT GUPTA | FY 2017 | 510246 |
Shareholding
The shareholding of Nabh Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nabh Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nabh Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nabh Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nabh Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAFCN1121K1Z2 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nabh Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nabh Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Bhavesh Kumar Singh was appointed as Director on 02 Jan 2016.
Frequently asked questions
Nabh Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 02 January 2016 (10+ years old) and is registered under CIN U24100DL2016PTC289196.
Nabh Pharmaceuticals has 2 current directors:
- Bhavesh Kumar Singh - Director
- Niraj Kumar Mishra - Director
The latest financial statements of Nabh Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 July 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Nabh Pharmaceuticals is 10AAFCN1121K1Z2, registered in Bihar.
The CIN (Corporate Identification Number) of Nabh Pharmaceuticals is U24100DL2016PTC289196. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nabh Pharmaceuticals was incorporated on 02 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nabh Pharmaceuticals by revenue are Granite Pharmaceuticals Private Limited, Medglobe Pharmaceuticals Private Limited, Optimize Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bhavesh Kumar Singh was appointed as Director on 02 Jan 2016. Niraj Kumar Mishra was appointed as Director on 02 Jan 2016.
The registered office of Nabh Pharmaceuticals is at House No.301 Khasra No – 6910 Ground Floor Anand Pur Dham Village Kar, Ala City, New Delhi, Delhi, India – 110081.
Nabh Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Nabh Pharmaceuticals is compliant as of 12 August 2026. The company is actively filing with the Registrar of Companies.